Recruitment of blood-derived inflammatory cells mediated via tumor necrosis factor-α receptor 1b exacerbates choroidal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 9, 2011, Pages 6101-6108

  Semkova, Irina ^a   Muether, Philipp S ^b   Kuebbeler, Mark ^b   Meyer, Klaus L ^b   Kociok, Norbert ^a   Joussen, Antonia M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARAFFIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1A; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1B; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; BRUCH MEMBRANE; CELL INVASION; CELL LABELING; CELL TRANSPORT; CONTROLLED STUDY; DISEASE EXACERBATION; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; IMMUNOCHEMISTRY; INFLAMMATORY CELL; LASER; MACROPHAGE; MEMBRANE RUPTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHIMERIN PROTEINS; CHOROIDAL NEOVASCULARIZATION; FLOW CYTOMETRY; LASER COAGULATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; WHOLE-BODY IRRADIATION;

EID: 80051539044     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5996     Document Type: Article

References (29)

1. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aeriological aspects of macular degeneration. Prog Retinal Eye Res. 2001;20:385-414.
2. Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:3578-3585.
3. Grossniklaus HE, Ling JH, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119-126.
4. Sakurai E, Taguchi H, Anand A, et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:2743-2749.
5. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, Cousins SW. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:3586-3592.
6. Caicedo A, Espinosa-Heidmann DG, Pina Y, Hernandez EP, Cousins SW. Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularisation. Exp Eye Res. 2005;81:38-47.
7. Espinosa-Heidmann DG, Caicedo A, Hernandez EP, Csaky KG, Cousins SW. Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularisation. Invest Ophthalmol Vis Sci. 2003;44:4914-4919.
8. Sengupta N, Caballero S, Mames RN, Butler JM, Scott EW, Grant MB. The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:4908-4913.
9. Tomita M, Yamada H, Adachi Y, et al. Choroidal neovascularization is provided by bone marrow cells. Stem Cells. 2004;22:21-26.
10. Sengupta N, Caballero S, Mames RN, Timmers AM, Saban D, Grant MB. Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors. Invest Ophthalmol Vis Sci. 2005;46:343-348.
11. Chan-Ling T, Baxter L, Afzal A, et al. Hematopoietic stem cells provide repair functions after laser-induced bruch's membrane rupture model of choroidal neovascularization. Am J Pathol. 2006; 168:1031-1043.
12. Yodoi Y, Sasahara M, Kameda T, Yoshimura N, Otani A. Circulating hematopoietic stem cells in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:5464-5472.
13. Thill M, Strunnikova NV, Berna MJ, et al. Late outgrowth endothelial progenotor cells in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:2696-2708.
14. Espinosa-Heidmann DG, Reinoso MA, Pina Y, Csaky KG, Caicedo A, Cousins SW. Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularisation. Exp Eye Res. 2005;369-378.
15. Tsutsumi C, Sonoda K, Egashira K, et al. The critical role of ocuar-infiltration macrophages in the development of choroidal neovascularization. J Leukoc Biol. 2003;74:25-32.
16. Tsutsumi-Miyahara C, Sonoda K-H, Egashira K, et al. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularization. Br J Ophthalmol. 2004;88: 1217-1222.
17. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1891-1898.
18. Barcelos LS, Talvani A, Teixeira AS, et al. Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1. J Leukoc Biol. 2005;78:352-358.
19. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987;329:630-632.
20. Cozzolino F, Torcia M, Aldinucci D, et al. Interleukin-1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA. 1990;87:6487-6491.
21. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA. 1987;84:5277-5281.
22. Shi X, Semkova I, Muether PS, Dell S, Kociok N, Joussen A. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res. 2006;83:1325-1334.
23. Majka S, Mcguire PG, Das A. Regulation of matrix metalloparoteinase expression by tumor necrosis factor in a murine model of retinal meovascularization. Invest Ophthalmol Vis Sci. 2002;43:20-266.
24. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45-65.
25. Carpentier I, Coornaert B, Beyaert R. Function and regulation of tumor necrosis factor type 2. Curr Med Chem. 2004;11:2205-2212.
26. Jasielska M, Semkova I, Shi X, et al. Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2010;51:3874-3883.
27. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002;8:607-612.
28. Semkova I, Fauser S, Lappas A, et al. Overexpression of FasL in retinal pigment epithelial cells redices choroidal neovascularisation. FASEB J. 2006;20:1689-1691.
29. Zhao X, Mohaupt M, Jiang J, Liu S, Li B, Qin Z, Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis. Cancer Res. 2007;67:4443-4450.